Yenlex Partners with Menxlab, a Digital Health Management Brand; Completed Series A Round, Financing of Hundreds of Millions of RMB
Beijing - Yenlex is pleased to announce that Menxlab, (www.menxlab.com) a digital health management platform, has recently completed its Series A round of financing.
This round of financing, led by China Growth Capital with the participation from SIG and Gaorong Capital, will be used mainly for product development and brand building.
Yenlex, a market leading law firm based in the People’s Republic of China, on behalf of Menxlab, fully participated in designing transaction structure, drafting, reviewing and negotiating transaction documents, as well as transaction closing.
Menxlab is a digital health management brand that focuses on personal health management for the new urban middle class (aged 25-40) and provides comprehensive solutions for consumption of medical products. Menxlab, taking advantage of rapid growth of the Internet Plus healthcare models, pursues innovative ways to come up with business solutions and reformulations in the fast-changing pharmaceutical industry and rapidly builds entry frameworks of operating business of online medical products and services.
With steady growth rates, Menxlab (www.menxlab.com) is capable of building a domestic consumer-oriented healthcare professional platform through its rich capacity and unique approach.
By 2020, Menxlab’s cumulative financing amount exceeded RMB100 million, largely accelerating the building of medical product systems.